"Subversive" substrates for the enzyme trypanothione disulfide reductase: alternative approach to chemotherapy of Chagas disease.
- 1 August 1988
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 85 (15) , 5374-5378
- https://doi.org/10.1073/pnas.85.15.5374
Abstract
The trypanosomatid flavoprotein disulfide reductase, trypanothione reductase, is shown to catalyze one-electron reduction of suitably substituted naphthoquinone and nitrofuran derivatives. A number of such compounds have been chemically synthesized, and a structure-activity relationship has been established; the enzyme is most active with compounds that contain basic functional groups in side-chain residues. The reduced products are readily reoxidized by molecular oxygen and thus undergo classical enzyme-catalyzed redox cycling. In addition to their ability to act as substrates for trypanothione reductase, the compounds are also shown to effectively inhibit enzymatic reduction of the enzyme9s physiological substrate, trypanothione disulfide. Under aerobic conditions, trypanothione reductase is not inactivated by these redox-cycling substrates, whereas under anaerobic conditions the nitrofuran compounds cause irreversible inactivation of the enzyme. When tested for biological activity against Trypanosoma cruzi trypomastigotes, many of the test compounds were trypanocidal, and this activity correlated with their relative ability to act as substrates for trypanothione reductase. The activity of the enzyme with these redox-cycling derivatives constitutes a subversion of its normal antioxidant role within the cell. For this reason these compounds may be termed "subversive" substrates for trypanothione reductase.This publication has 15 references indexed in Scilit:
- Trypanothione dependent peroxide metabolism in Crithidia fasciculata and Trypanosoma bruceiMolecular and Biochemical Parasitology, 1987
- Human interleukin 1 induces interleukin 1 gene expression in human vascular smooth muscle cells.The Journal of Experimental Medicine, 1987
- Chemotherapy for Chagas' Disease: A Perspective of Current Therapy and Considerations for Future ResearchClinical Infectious Diseases, 1986
- Hydrogen peroxide metabolism in Trypanosoma bruceiMolecular and Biochemical Parasitology, 1986
- Purification and characterization of trypanothione reductase from Crithidia fasciculata, a new member of the family of disulfide-containing flavoprotein reductasesBiochemistry, 1986
- A neuraminidase from Trypanosoma cruzi removes sialic acid from the surface of mammalian myocardial and endothelial cells.Journal of Clinical Investigation, 1986
- Trypanothione: A Novel Bis(glutathionyl)spermidine Cofactor for Glutathione Reductase in TrypanosomatidsScience, 1985
- Identification of a novel, thiol-containing co-factor essential for glutathione reductase enzyme activity in trypanosomatidsMolecular and Biochemical Parasitology, 1985
- An approach to the development of new drugs for African trypanosomiasis.The Journal of Experimental Medicine, 1978
- Mammalian cell toxicity of nitro compounds: Dependence upon reduction potentiaklBiochemical and Biophysical Research Communications, 1976